PBMs requiring generics to be short cycled if they were approved with an NDA instead of an ANDA?

I received an email today that some insurance plans are requiring certain generic medications to be dispensed in short cycles because the NDC was tied to an NDA instead of an ANDA.  This is something that I had never even heard of being a possibility.  Is CMS aware of this?  Was it intended?  How on earth are we supposed to comply with the short cycle dispensing rules if there are also some generics that must be dispensed in short cycle depending on what type of paperwork was filed for their FDA approval?

User login


To prevent automated spam submissions leave this field empty.
Become a Member Today ASCP